Biotech is going to San Francisco. And cash is going to biotech.
During the first full week of January, private biotechs raised at least $2.29 billion in new capital, according to an Endpoints News tally …
Read More from Endpoints News
Private and public biotechs go on $4.9B funding spree ahead of JPM
